Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05266040 · ClinicalTrials.gov registry record · Phase 2
Valacyclovir in Pain Management of Acute Apical Abscesses
A Phase 2 study of Pain, Acute and Acute Apical Abscess, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05266040 is a Phase 2 study of Pain, Acute and Acute Apical Abscess that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 60 participants, below the 100-participant average among 31 other Pain, Acute trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05266040, a Phase 2 study of Pain, Acute and Acute Apical Abscess, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The Virus in Endodontics (VE) phase I pilot study for preoperative pain will be analyzed and adjusted for the Phase II clinical trial. The Phase II clinical trial on preoperative pain, postoperative pain, and clinical healing will involve 250 patients. Patients will be recruited from the same pool of participants as the Phase II clinical trial. Preoperative cone beam computed tomography (CBCT) scans will be taken as well as three and six month postoperative CBCT scans. The secondary outcomes form the Phase II randomized clinical trial will be clinical success and visible radiographic healing determined by CBCT images.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Valacyclovir 500 MG
Study Locations (1)
California
- UCSF Dental - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-10-25 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05266040
The ClinicalTrials.gov registry entry for NCT05266040 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 31 other Pain, Acute trials with a reported enrollment target (40% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain, Acute appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05266040 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05266040 about?
NCT05266040 is a clinical study titled "Valacyclovir in Pain Management of Acute Apical Abscesses". The Virus in Endodontics (VE) phase I pilot study for preoperative pain will be analyzed and adjusted for the Phase II clinical trial. The Phase II clinical trial on preoperative pain, postoperative pain, and clinical healing will involve 250 patients. Patients will be recruited from the same pool o...
What is the current status of trial NCT05266040?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2023-10-25. Estimated completion is 2025-12-31.
What conditions does trial NCT05266040 study?
This clinical trial studies the following conditions: Pain, Acute, Acute Apical Abscess.
What interventions are being tested in trial NCT05266040?
The interventions under investigation include: Placebo (DRUG), Valacyclovir 500 MG (DRUG).
Who is sponsoring clinical trial NCT05266040?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05266040 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
RECRUITING · Phase 2
-
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
ACTIVE NOT RECRUITING · Phase 2
-
Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
COMPLETED · Phase 2
-
RTMS for Treatment of Pain and Craving
COMPLETED · Phase 2
-
TENS Unit for Analgesia During IUD Insertion
RECRUITING · NA
-
Variability in Analgesic Response to Ibuprofen
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.